Citalopram vs Clomipramine vs Placebo in Recurrent Depression
NCT ID: NCT01575158
Last Updated: 2012-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
1997-10-31
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
NCT01557946
Cognitive Therapy for Recurrent Depression
NCT00118404
Prevention of Recurrence in Depression With Drugs and CT
NCT00057577
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms
NCT01919216
Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders
NCT00609531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
citalopram
citalopram
Citalopram
clomipramnine
clomipramine
Clomipramine
placebo
placebo
placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Citalopram
Clomipramine
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sustained response achieved (3 consecutive monthly ratings at the HDS below 13)after a treatment requiring index episode
Exclusion Criteria
* Pregnancy
* Substance abuse
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish University Antidepressant Group
UNKNOWN
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DUAG-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.